Gleamer, a leader in AI-powered medical imaging, has expanded into MRI analysis through the acquisition of Caerus Medical and a merger with Pixyl. These moves accelerate Gleamer’s goal of developing AI-driven solutions for comprehensive medical imaging beyond its existing X-ray and mammography tools.
Founded in 2017, Gleamer has built an AI assistant for radiologists, designed to improve diagnostic accuracy. The company’s technology is used by 2,000 institutions across 45 countries, processing 35 million examinations globally. With CE and FDA approvals, Gleamer’s AI solutions enhance detection in bone trauma, chest X-rays, and orthopedic imaging.
By integrating MRI-focused expertise from Caerus Medical and Pixyl, Gleamer aims to cover all MRI use cases within three years, reinforcing its position as a key innovator in AI-powered radiology.
